Copyright
©The Author(s) 2003.
World J Gastroenterol. Mar 15, 2003; 9(3): 495-498
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.495
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.495
Table 9 Immunobgice function prior to and after NDV vaccination therapy
| Item | n | Before therapy(-x ± s) | After therapy (-x ± s) | P |
| NK | 10 | 24.65 ± 7.21 | 36.58 ± 11.87 | < 0.05 |
| CD3+ | 10 | 67.15 ± 2.43 | 71.12 ± 2.86 | < 0.01 |
| CD4+ | 10 | 38.23 ± 3.01 | 41.62 ± 2.71 | < 0.01 |
| CD8+ | 10 | 30.55 ± 1.21 | 29.84 ± 2.43 | > 0.05 |
| CD4+/CD8+ | 10 | 1.23 ± 0.12 | 1.41 ± 0.13 | < 0.05 |
- Citation: Liang W, Wang H, Sun TM, Yao WQ, Chen LL, Jin Y, Li CL, Meng FJ. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet. World J Gastroenterol 2003; 9(3): 495-498
- URL: https://www.wjgnet.com/1007-9327/full/v9/i3/495.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i3.495